文献速递肝胆胰外科围术期管理与 ERAS

北美30年活体肝移植供者死亡率分析

Over 30 Years of Living Liver Donation in North America: Mortality Associated With Donation.
PubMed 文献 · Ann Surg · 2025-08-07

该研究基于美国OPTN数据库1989至2023年9400例活体肝移植供者及加拿大1550例供者数据,分析供者肝切除术后死亡情况。美国供者死亡79例(0.8%),加拿大4例(0.3%),围手术期/术后死亡风险随时间下降至0.02%,2016年后无此类死亡。90天内死亡与肝切除相关,90天后死亡与肝切除无关。

要点

  • 北美活体肝移植供者术后死亡罕见,约每5000例供者中1例死亡。
  • 围手术期/术后死亡风险随时间下降,2016年后无此类死亡报告。
  • 90天内死亡与肝切除相关,90天后死亡与肝切除无关。

核心结论

  • 北美活体肝移植供者肝切除术后围手术期/术后死亡罕见,约每5000例供者中1例死亡。
  • 90天内死亡与肝切除相关,90天后死亡与肝切除无关。
  • 明确活体肝移植供者结局对供者选择和咨询至关重要。

研究设计与样本

  • 美国1989至2023年所有活体肝移植供者通过OPTN数据库识别,加拿大中心提供汇总数据。
  • 美国9400例供者肝切除术,加拿大1550例。
  • 对美国供者死亡后5年内的中心进行调查以确定死因。

主要发现

  • 美国9400例供者肝切除术中79例死亡(0.8%),加拿大1550例中4例死亡(0.3%)。
  • 从捐献到死亡的中位时间为8.8年(范围0天至24.5年)。
  • 6例围手术期死亡(<30天),2例术后死亡(30-90天),17例死亡在90天至5年之间,53例死亡在5年后。
  • 围手术期/术后死亡风险随时间下降(0.19%至0.02%),2016年后无死亡。
  • 围手术期/术后死因包括心血管骤停、肝衰竭、呼吸骤停和感染;90天至5年死因包括创伤、自杀、药物过量和癌症。

临床怎么用

  • 供者选择咨询时应告知围手术期/术后死亡风险约每5000例中1例,且近年风险下降。
  • 应告知供者90天后死亡与肝切除无关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study is to determine the incidence of death following living donor hepatectomy. BACKGROUND: Greater than 11,000 living donor hepatectomies have been performed in the United States (US) and Canada over the last 3 decades. Risk of donor death is unknown. METHODS: All living liver donors in the US from 1989 to 2023 were identified within the Organ Procurement Transplantation Network (OPTN) database. Donor death was ascertained. Summary data for number of donors and deaths was collected directly from Canadian centers. US centers with a death within 5 years of donation were surveyed to determine cause of death. RESULTS: In the US, 9400 donor hepatectomies were performed with 79 deaths (0.8%). In Canada 1550 were performed with 4 deaths (0.3%). Median time from donation to death was 8.8 years (0 days-24.5 years). Six deaths occurred perioperatively (<30 days), 2 postoperatively (30-90 days), 17 between 90 days and 5 years, and 53 beyond 5 years. Risk of perioperative/postoperative death decreased over time (0.19%-0.02%) with no deaths since 2016. Causes of perioperative/postoperative death included cardiovascular arrest, liver failure, respiratory arrest, and infection. Causes of death between 90 days and 5 years included trauma, suicide, drug overdose, and cancer. CONCLUSIONS: Perioperative/postoperative death following living donor hepatectomy is rare in North America, with ∼1 death per 5000 donors. Causes of death within 90 days were associated with hepatectomy but deaths beyond 90 days were not attributable to hepatectomy. Defining outcomes after living liver donation is vital for donor selection and counseling.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. King EA, Hernandez-Alejandro R, Emamaullee J, et al. Over 30 Years of Living Liver Donation in North America: Mortality Associated With Donation. Ann Surg. 2025. PMID: 40772632. doi:10.1097/SLA.0000000000006895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。